One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study

Secukinumab efficacy in patients with PsA is not dependent on patients’ body mass index

(2020) Ilenia Pantano et al.   ANNALS OF THE RHEUMATIC DISEASES

2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis

(2019) Michael M. Ward et al.   Arthritis & Rheumatology

Axial psoriatic arthritis: the impact of underdiagnosed disease on outcomes in real life

(2018) Sibel Zehra Aydin et al.   CLINICAL RHEUMATOLOGY

Comparative Analysis and Predictors of 10-year Tumor Necrosis Factor Inhibitors Drug Survival in Patients with Spondyloarthritis: First-year Response Predicts Longterm Drug Persistence

(2018) Irini D. Flouri et al.   JOURNAL OF RHEUMATOLOGY

Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison

(2018) Joy Feld et al.   Nature Reviews Rheumatology

In situ T regulatory cells and Th17 cytokines in paired samples of leprosy type 1 and type 2 reactions

(2018) Maurício Barcelos Costa et al.   PLoS One

OUP accepted manuscript

(2018)   RHEUMATOLOGY

Performance of 3 Enthesitis Indices in Patients with Peripheral Spondyloarthritis During Treatment with Adalimumab

(2017) Philip J. Mease et al.   JOURNAL OF RHEUMATOLOGY

Enthesitis: from pathophysiology to treatment

(2017) Georg Schett et al.   Nature Reviews Rheumatology

Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study

(2017) Iain B McInnes et al.   RHEUMATOLOGY

Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study

(2016) Jürgen Braun et al.   ANNALS OF THE RHEUMATIC DISEASES

Increasing smoking intensity is associated with increased disease activity in axial spondyloarthritis

(2016) Sizheng Zhao et al.   RHEUMATOLOGY INTERNATIONAL

Impact of training on concordance among rheumatologists and dermatologists in the assessment of patients with psoriasis and psoriatic arthritis

(2016) Carlo Salvarani et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score

(2015) Monika M Schoels et al.   ANNALS OF THE RHEUMATIC DISEASES

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

(2015) Iain B McInnes et al.   LANCET

Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis

(2015) Philip J. Mease et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies

(2015) Francesco Caso et al.   Therapeutic Advances in Chronic Disease

Extra-articular manifestations in psoriatic arthritis patients

(2014) Rosario Peluso et al.   CLINICAL RHEUMATOLOGY

Ankylosing enthesitis associated with up-regulated IFN-γ and IL-17 production in (BXSB × NZB) F1 male mice: a new mouse model

(2014) Yasuharu Abe et al.   Modern Rheumatology

Body weight, gender and response to TNF-  blockers in axial spondyloarthritis

(2014) E. Gremese et al.   RHEUMATOLOGY

Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype?

(2012) Dominique Baeten et al.   ARTHRITIS AND RHEUMATISM

Immunomodulation in psoriatic arthritis: Focus on cellular and molecular pathways

(2012) Maria Sole Chimenti et al.   AUTOIMMUNITY REVIEWS

IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells

(2012) Jonathan P Sherlock et al.   NATURE MEDICINE

ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis

(2008) D van der Heijde et al.   ANNALS OF THE RHEUMATIC DISEASES